BioCorRx Inc. (BICX) stock
BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
$0.25+0.00 (0.00%)
Close on Oct 19, 2026Market cap $7.30MP/E –Yield –
BioCorRx gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
BioCorRx's gross profit for the twelve months ending Jun 30, 2025 was $313.14K, up 1625.6% year over year. For fiscal 2024 it was $6.00K, down 88.7% from the year before. Over ten years it grew -39.7% a year on average. The highest annual figure on record is $949.96K in fiscal 2014.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.00K | -88.7% |
| FY2023 | Dec 31, 2023 | $53.17K | -73.2% |
| FY2022 | Dec 31, 2022 | $198.56K | +368.4% |
| FY2021 | Dec 31, 2021 | $42.39K | +58.9% |
| FY2020 | Dec 31, 2020 | $26.67K | -83.2% |
| FY2019 | Dec 31, 2019 | $158.59K | -22.9% |
| FY2018 | Dec 31, 2018 | $205.70K | -38.4% |
| FY2017 | Dec 31, 2017 | $333.66K | -36.6% |
| FY2016 | Dec 31, 2016 | $526.34K | -31.9% |
| FY2015 | Dec 31, 2015 | $772.76K | -18.7% |
| FY2014 | Dec 31, 2014 | $949.96K | +71.2% |
| FY2013 | Dec 31, 2013 | $554.78K | +19.1% |
| FY2012 | Dec 31, 2012 | $465.68K | +25.4% |
| FY2011 | Dec 31, 2011 | $371.35K | – |
| FY2010 | Dec 31, 2010 | -$11.82K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$57.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $189.36K | – |
| Q2 FY2025 | Jun 30, 2025 | $178.24K | +4306.4% |
| Q1 FY2025 | Mar 31, 2025 | $134.90K | +6807.3% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.05K | -56.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.95K | -93.9% |
| Q4 FY2023 | Dec 31, 2023 | $5.89K | -69.0% |
| Q3 FY2023 | Sep 30, 2023 | $6.26K | -71.2% |
| Q2 FY2023 | Jun 30, 2023 | $9.26K | -2.5% |
| Q1 FY2023 | Mar 31, 2023 | $31.77K | – |
| Q1 FY2022 | Mar 31, 2022 | $18.98K | +43.2% |
| Q2 FY2021 | Sep 30, 2021 | $21.72K | +251.1% |
| Q1 FY2021 | Mar 31, 2021 | $9.49K | -32.0% |
| Q4 FY2020 | Dec 31, 2020 | -$6.73K | -118.6% |
| Q3 FY2020 | Sep 30, 2020 | $13.26K | -45.4% |
| Q2 FY2020 | Jun 30, 2020 | $6.19K | -82.6% |
| Q1 FY2020 | Mar 31, 2020 | $13.96K | -77.6% |
| Q4 FY2019 | Dec 31, 2019 | $36.26K | – |
| Q3 FY2019 | Sep 30, 2019 | $24.27K | -58.2% |
| Q2 FY2019 | Jun 30, 2019 | $35.61K | -22.0% |
| Q1 FY2019 | Mar 31, 2019 | $62.45K | -45.7% |
| Q4 FY2018 | Dec 31, 2018 | -$12.90K | -132.8% |
| Q3 FY2018 | Sep 30, 2018 | $58.00K | -58.4% |
| Q2 FY2018 | Jun 30, 2018 | $45.68K | +4.1% |
| Q1 FY2018 | Mar 31, 2018 | $114.92K | +3.6% |
| Q4 FY2017 | Dec 31, 2017 | $39.32K | -39.3% |
| Q3 FY2017 | Sep 30, 2017 | $139.59K | +7.4% |
| Q2 FY2017 | Jun 30, 2017 | $43.88K | -69.0% |
| Q1 FY2017 | Mar 31, 2017 | $110.88K | -41.6% |
| Q4 FY2016 | Dec 31, 2016 | $64.74K | +6.7% |
| Q3 FY2016 | Sep 30, 2016 | $129.91K | – |
| Q2 FY2016 | Jun 30, 2016 | $141.73K | – |
| Q1 FY2016 | Mar 31, 2016 | $189.96K | – |
| Q4 FY2015 | Dec 31, 2015 | $60.68K | – |
See a number that looks wrong?